Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension.
about
Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) geneNerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats.Presynaptic receptors in hypertension.Physiological level of norepinephrine increases adenine nucleotides hydrolysis in rat blood serumPre- and postjunctional beta-adrenoreceptors and hypertension.Mechanisms involved in the increased vascular resistance in hypertension.Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.Prostaglandin E2 inhibits and indomethacin enhances noradrenaline release in isolated kidneys of adult spontaneously hypertensive ratsEnhanced sympathetic neurotransmission in the tail artery of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX)-treated rats.Inhibition of noradrenaline release by omega-conotoxin GVIA in the rat tail artery.Expression of beta-adrenoceptors on circulating mononuclear cells in hypertensives and normotensives before and after reduction of central sympathetic outflow by clonidine.Altered function of nitrergic nerves inhibiting sympathetic neurotransmission in mesenteric vascular beds of renovascular hypertensive rats.Increase of angiotensin-converting enzyme activity and peripheral sympathetic dysfunction could contribute to hypertension development in streptozotocin-induced diabetic rats.Neurons from neonatal hypertensive rats exhibit abnormal membrane properties in vitro.Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats.
P2860
Q34642358-21B0EA9C-2DCD-4C0B-A48B-2255E1206002Q37038881-4421BDC5-A245-4D00-8D35-7893EACEC6BBQ37895598-88E30C8A-58E0-4C84-BD8B-C020B4DA2340Q39393354-FCE6EAC1-5BF1-4791-B4BB-7E5E1E70797DQ39470203-25371E66-349B-4C64-B68F-20552F95A3F2Q40903759-2CEFE010-80AC-441F-85F4-A116C8928E57Q41138497-7B64596C-1C62-4BE3-AD5F-9E6FE3306077Q41909196-A5CBEF17-D71C-4BA5-B14D-81E2E0518D41Q42214102-A36C895D-2197-4009-B5A9-41B3730DFA27Q42276042-AF7837AC-31E7-4D24-9AB1-238B11E39436Q42496719-FA160E27-C191-45EB-95CA-50179A436B64Q43105419-46777B2F-B76A-4451-98FB-AFC785595636Q44008076-51313F2C-0F40-4DED-A800-E861BCCCD6EAQ45045786-310BF0BD-44A5-4BD1-8471-0B23DF9AC52BQ46927669-392137BE-9624-4C7F-9B4F-2CF801881885
P2860
Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Alterations in the release of ...... ctor junction in hypertension.
@en
Alterations in the release of ...... ctor junction in hypertension.
@nl
type
label
Alterations in the release of ...... ctor junction in hypertension.
@en
Alterations in the release of ...... ctor junction in hypertension.
@nl
prefLabel
Alterations in the release of ...... ctor junction in hypertension.
@en
Alterations in the release of ...... ctor junction in hypertension.
@nl
P1476
Alterations in the release of ...... ctor junction in hypertension.
@en
P2093
Meldrum MJ
Westfall TC
P304
P356
10.1146/ANNUREV.PA.25.040185.003201
P577
1985-01-01T00:00:00Z